Developer docs
API playgroundTry for free, no card

Search company profiles

San Raffaele

Full company profile

uuid000teui

Namestring
San Raffaele
Legal namestring
San Raffaele S.p.A.
Websiteurl
sanraffaele.it
Company typeenum
Private
Founded yearstring
-
Descriptiontext

San Raffaele S.p.A. is a privately held Italian healthcare company headquartered in Rome at Via di Val Cannuta 247, operating an integrated healthcare network (the 'SR Network') spanning hospitals, rehabilitation centers, residential care facilities (RSA), outpatient clinics, and home care services across Lazio, Abruzzo, Puglia, Basilicata, Campania, and Sardinia. The network comprises over 4,000 inpatient and residential beds and employs more than 4,000 health professionals, with services delivered through both Italian National Health Service (SSN) accreditation via regional ASL (Aziende Sanitarie Locali) agreements and private-pay channels. The company is structured around 14+ wholly-owned operating subsidiaries (S.r.l. entities), each holding separate SSN accreditations, and includes the IRCCS San Raffaele research hospital and the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) as scientific research anchors.

The core technology stack combines advanced diagnostic imaging—including Siemens MAMMOMAT Inspiration PRIME Edition 3D mammography with tomosynthesis (up to 30% dose reduction) and the newly inaugurated digital PET-CT scanner with AI integration at IRCCS San Raffaele Cassino—with rehabilitation technologies such as EKSO and ATLAS 2030 robotic exoskeletons for adult and pediatric neurorehabilitation respectively. The SR-TIGET gene therapy platform supports parallel development of therapies for lysosomal storage diseases (MPS IVA, GLB1-related disorders, and alpha-mannosidosis), and in March 2026 established the first Danaher Beacon in continental Europe via a multi-year partnership with Cytiva, Aldevron, and IDT to advance lentiviral vector production and gene editing. Digital infrastructure includes the SR Telemedicina platform for remote consultations, an integrated Single Reservation Center (CUP), online booking (prenotazioni.sanraffaele.it), and the Referti Online portal for report retrieval.

San Raffaele's business model operates through five principal revenue streams: regulated SSN tariff reimbursement across the accredited facility network; private-pay outpatient services and promotional screening packages (e.g., the SR Donna women's health screening package at €120); continuing medical education (ECM) courses delivered through its national ECM Provider status; PNRR and Fondazione Telethon research grants supporting SR-TIGET gene therapy programs; and ancillary services including home care (ADI – Assistenza Domiciliare Integrata). Customer access flows through GP/ASL referrals for SSN services, direct-to-consumer booking for private-pay offerings, and centralized Customer Care for international patients, with go-to-market spanning institutional SSN contracts, scientific conference participation, and event-driven reputation building.

Short descriptiontext

San Raffaele S.p.A. operates an integrated Italian healthcare network (SR Network) of 16+ hospitals, rehabilitation centers, nursing homes, and outpatient clinics across Lazio, Abruzzo, Puglia, Basilicata, and Sardinia, with 4,000+ beds and 4,000+ health professionals serving general, rehabilitation, and elderly patients through SSN-accredited and private-pay services, including the IRCCS research hospital and the SR-TIGET gene therapy institute.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersRoma, Italy
HQ citystring
Roma
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices18 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rehabilitation services, residential elderly care, diagnostic imaging, neurorehabilitation programs, home healthcare services
Industry5 codes
1Home Health Therapy Services (PT/OT/SLP) Providers
CodeHLAFAEAMPrimaryYes
2Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
CodeHLALABADPrimaryNo
3Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
CodeHLAGACAHPrimaryNo
4Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows)
CodeHLALAFAHPrimaryNo
5Private Duty 24/7 Nursing (RN/LPN) In-Home Care
CodeHSABAHAJPrimaryNo
NAICS code5 codes
  • Home Health Care Services62161
  • Nursing Care Facilities (Skilled Nursing Facilities)62311
  • Diagnostic Imaging Centers621512
  • Services for the Elderly and Persons with Disabilities624120
  • Services for the Elderly and Persons with Disabilities62412
SIC code4 codes
  • Services-Home Health Care Services8082
  • Services-Skilled Nursing Care Facilities8051
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Nursing & Personal Care Facilities8050
Product category
Integrated Healthcare and Rehabilitation Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Healthcare Service Delivery
TypeSubscription Recurring
Description

Direct revenue from patient care services delivered across the SR Network of hospitals, rehabilitation centers, nursing homes (RSA), outpatient clinics, and home care (ADI). Services are provided both through the National Health Service (SSN/accreditation) and as private-pay. Revenue is generated from diagnostic procedures, specialist visits, inpatient stays, rehabilitation programs, and home care.

sanraffaele.it
2National Health Service (SSN) Accreditations
TypeManaged Services
Description

Facilities operate under regional health system accreditation agreements, with funding flows from ASL (Aziende Sanitarie Locali) based on authorized capacity and service volume. Multiple subsidiaries hold separate SSN accreditations (Casa di Cura Nepi, Centro Geriatrico Matera, IRCCS San Raffaele Roma, Medica Group, Montecompatri, Nuova Nomentana Hospital, Portuense, Residenza dei Renai, Rocca di Papa, Rosa del Marganai, RSA San Raffaele Sabaudia, San Raffaele S.p.A., Villa dei Fiori, Villa Monica, Viterbo, SGAS).

sanraffaele.it
3Continuing Medical Education (ECM)
TypeProfessional Services
Description

The San Raffaele Training Center is a National ECM Provider recognized by the Commissione Nazionale per la Formazione Continua, generating revenue from accredited training courses for healthcare professionals.

sanraffaele.it
4Research Grants and PNRR Funding
TypeLicensing Royalties
Description

IRCCS San Raffaele participates in projects funded by Italy's National Recovery and Resilience Plan (PNRR), with grants supporting gene therapy research, robotics rehabilitation, and translational medicine. Fondazione Telethon co-funds SR-TIGET gene therapy programs.

firstonline.info
5Private-Pay Diagnostic and Screening Packages
TypeOne Time License
Description

Direct consumer revenue from promotional screening packages (e.g., SR Donna breast screening at €120) and private specialist consultations not covered by SSN.

sanraffaele.it
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1SR Donna – Women's Health Screening Package
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€120 total for a package including gynecological consultation, Pap test, mammography, and breast ultrasound. Offered as a promotional screening week package at San Raffaele Termini Poliambulatory.

sanraffaele.it
2SSN (National Health Service) Accredited Services
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Services provided under regional health system accreditation (SSN/SRN), with tariffs regulated by ASL agreements. Patients access services with health card referral or authorization from their local health authority.

sanraffaele.it
3Private-Pay Specialist Consultations and Diagnostics
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Private-pay options available for all specialist visits and diagnostic imaging (MRI, CT, mammography, etc.) for patients without SSN coverage or choosing private access.

sanraffaele.it
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

San Raffaele S.p.A. operates the SR Network, an integrated Italian healthcare system providing diagnostic imaging, specialist outpatient care, inpatient and residential rehabilitation (RSA), home care (ADI), and telemedicine through more than 16 facilities with 4,000+ beds and 4,000+ health professionals. Services are delivered both under Italian National Health Service (SSN) accreditation and as private-pay offerings, with a research arm (IRCCS San Raffaele and SR-TIGET) advancing gene therapy and neurorehabilitation science.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 30% dose reduction in mammography with maintained image quality (PRIME technology)
+4 more records
Product overview1 text field

San Raffaele is a comprehensive healthcare network (SR Network) providing integrated healthcare, scientific research, and assistance services through over 40 facilities with more than 4,000 beds and 4,000 health professionals. The network offers diagnostic imaging services (including 3D mammography with tomosynthesis, digital PET-TC with AI), rehabilitation services (neuromotor, equestrian rehabilitation, developmental age), telemedicine (SR Telemedicina), home care (ADI), outpatient specialist clinics, and operates research institutes including IRCCS San Raffaele for neuroscience and the San Raffaele-Telethon Institute for Gene Therapy. Patients can access services through online booking (CUP) and digital report retrieval.

Product and service10 records
1SR Network (San Raffaele Healthcare Network)
CategoryIntegrated healthcare network
Description

Integrated healthcare network providing diagnostics, specialist outpatient care, inpatient rehabilitation, residential elderly care (RSA), home care (ADI), and research services across multiple Italian regions.

2Outpatient Specialist Clinics
CategoryOutpatient healthcare services
Description

SSN-affiliated outpatient clinics offering specialist services including cardiology, dermatology, diagnostic imaging, endocrinology, gynecology, neurology, orthopedics, otolaryngology, physiatrics, speech therapy, ultrasound, and urology.

3Specialized Rehabilitation Services (Neurorehabilitation and Equestrian Rehabilitation)
CategorySpecialized rehabilitation services
Description

Specialized rehabilitation including physical, mental, and sensory rehabilitation, equestrian rehabilitation, onotherapy, robotic exoskeleton therapy (EKSO, ATLAS 2030), music therapy, and neuroprosthetics. Includes 95 residential beds and 35 semiresidential beds at San Raffaele Viterbo.

4ADI – Assistenza Domiciliare Integrata (Integrated Home Care)
CategoryHome care services
Description

Integrated home care service delivering healthcare assistance to patients in their homes across the SR Network catchment area.

5SR Telemedicina
CategoryTelemedicine service
Description

Telemedicine service enabling remote medical consultations, online report access, and home care coordination.

6San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET)
CategoryGene therapy research
Description

Research institute developing gene therapy platforms for lysosomal storage diseases (MPS IVA, GLB1-related disorders, alpha-mannosidosis) and next-generation genomic medicine including lentiviral vector production and gene editing in hematopoietic stem cells.

7IRCCS San Raffaele Neuroscience and Neurorehabilitation Unit
CategoryResearch and clinical unit
Description

Research and clinical unit focused on neuroscience and neurorehabilitation, including the CDCD (Centro Disturbi Cognitivi e Demenze), formally recognized as a Center of Excellence by Lazio Region.

8San Raffaele Formazione (Continuing Medical Education / ECM Provider)
CategoryMedical education and training
Description

National ECM Provider delivering accredited continuing medical education and specialized training programs for healthcare professionals.

9SR Donna Women's Health Screening Package
CategoryPreventive screening package
Description

Private-pay women's health screening package combining gynecological consultation, Pap test, mammography, and breast ultrasound for early detection of breast and gynecological conditions.

10Residential Care (RSA) Services
CategoryResidential and home care services
Description

Residential, semi-residential, hospice, and integrated home care services for elderly and non-self-sufficient adults, including dementia care (CDCD), across multiple SSN-accredited facilities.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-23
Description

Cytiva and SR-TIGET launched a multi-year collaboration to advance next-generation genomic medicine platforms, establishing the first Danaher Beacon on the European continent. The initiative focuses on optimizing lentiviral vector production and homology-directed repair-based gene editing in hematopoietic stem cells. SR-TIGET provides scientific leadership while Cytiva provides manufacturing expertise. Partners Aldevron and IDT also participate. The goal is to help developers overcome bottlenecks in cell and gene therapy translation, scalability, and reproducibility to make breakthrough advanced therapies more sustainable and accessible to patients.

Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2026-03-23
Description

Aldevron participates as a technology partner alongside Cytiva in the SR-TIGET genomic medicine collaboration, contributing to the Danaher Beacon initiative for cell and gene therapy manufacturing optimization.

Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2026-03-23
Description

IDT participates alongside Cytiva and Aldevron in the SR-TIGET collaboration as a technology partner contributing to the Danaher Beacon genomic medicine platform for gene editing optimization.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2004-11-26
Description

Tosinvest Sanità is the parent healthcare group of San Raffaele, organizing quality initiatives such as the World Quality Day in Healthcare with Fondazione San Raffaele, attended by Italian Ministry of Health officials. The group oversees the SR Network of healthcare facilities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2004-11-17
Description

San Raffaele served as venue and institutional partner for World COPD Day conference organized by the Italian Association of COPD Patients, under the auspices of the WHO and NIH, recognizing San Raffaele's translational research role in rehabilitation and prevention.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2004-11-17
Description

NIH Bethesda co-sponsored the World COPD Day conference held at San Raffaele, acknowledging San Raffaele's scientific contributions to respiratory rehabilitation and prevention research.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

IRCCS San Raffaele and Ospedale Bambino Gesù jointly organize the International Epilepsy Course (XIII edition in Tagliacozzo), combining clinical and research expertise in pediatric and adult epilepsy.

8AREDA – Amateur Sports Association
Strategic tierSupportingTypeOthers
Description

AREDA provides technical support for equestrian rehabilitation activities at San Raffaele Viterbo's Equestrian Rehabilitation Center, including free-roaming Haflinger horses for therapy, mini ponies for children, and donkey onotherapy sessions.

sanraffaele.it
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Italy's largest private hospital group, which notably owns the IRCCS Ospedale San Raffaele in Milan (distinct from the Rome-based San Raffaele S.p.A. analyzed here). Comparable as an Italian multi-facility hospital network with research capabilities and SSN-accredited operations.

TypeDirect peer
Description

Italian private hospital group with IRCCS-recognized research (Humanitas Research Hospital) and integrated care across multiple specialties. Directly comparable to San Raffaele as an Italian multi-site hospital/research network with SSN accreditation and academic partnerships.

TypeDirect peer
Description

Italian healthcare group operating hospitals, rehabilitation centers, nursing homes (RSA), and home care services. Closely matches San Raffaele's mix of rehabilitation, residential care, and acute services in Italy.

TypeDirect peer
Description

Italian private hospital and rehabilitation network with multiple facilities across regions. Comparable for multi-site Italian hospital/rehabilitation operations and SSN accreditation model.

TypeDirect peer
Description

Italian private healthcare operator focused on rehabilitation, RSA residential care, and psychiatric services. Directly comparable to San Raffaele's rehabilitation and elderly care footprint in central Italy.

TypeBroad incumbent
Description

Major European operator of nursing homes, rehabilitation clinics, and home care services with operations in France, Italy, Germany, and beyond. Comparable to San Raffaele's residential, rehabilitation, and home care (ADI) service lines.

TypeBroad incumbent
Description

Large European operator of nursing homes, post-acute and rehabilitation clinics. Comparable for the RSA/nursing home and rehabilitation components of San Raffaele's network, though at significantly larger scale.

TypeDirect peer
Description

European operator of advanced diagnostic imaging centers (MRI, CT, PET-CT) including in Italy. Comparable to San Raffaele's diagnostic imaging investments (digital PET-CT, 3D mammography) at the facility/outpatient level.

TypeOthers
Description

Italian non-profit funding gene therapy research, long-standing co-funder of SR-TIGET. Adjacent player — represents the demand-side ecosystem for San Raffaele's gene therapy platform rather than a direct competitor.

TypeDirect peer
Description

Major Italian IRCCS university hospital in Rome with strong research portfolio. Comparable to IRCCS San Raffaele Roma in terms of designation, research prestige, and acute specialty services within the same metropolitan market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile8 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries15 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

San Raffaele

Integrated Healthcare and Rehabilitation Servicessanraffaele.it

San Raffaele S.p.A. operates an integrated Italian healthcare network (SR Network) of 16+ hospitals, rehabilitation centers, nursing homes, and outpatient clinics across Lazio, Abruzzo, Puglia, Basilicata, and Sardinia, with 4,000+ beds and 4,000+ health professionals serving general, rehabilitation, and elderly patients through SSN-accredited and private-pay services, including the IRCCS research hospital and the SR-TIGET gene therapy institute.

What San Raffaele does

San Raffaele S.p.A. is a privately held Italian healthcare company headquartered in Rome at Via di Val Cannuta 247, operating an integrated healthcare network (the 'SR Network') spanning hospitals, rehabilitation centers, residential care facilities (RSA), outpatient clinics, and home care services across Lazio, Abruzzo, Puglia, Basilicata, Campania, and Sardinia. The network comprises over 4,000 inpatient and residential beds and employs more than 4,000 health professionals, with services delivered through both Italian National Health Service (SSN) accreditation via regional ASL (Aziende Sanitarie Locali) agreements and private-pay channels. The company is structured around 14+ wholly-owned operating subsidiaries (S.r.l. entities), each holding separate SSN accreditations, and includes the IRCCS San Raffaele research hospital and the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) as scientific research anchors.

The core technology stack combines advanced diagnostic imaging—including Siemens MAMMOMAT Inspiration PRIME Edition 3D mammography with tomosynthesis (up to 30% dose reduction) and the newly inaugurated digital PET-CT scanner with AI integration at IRCCS San Raffaele Cassino—with rehabilitation technologies such as EKSO and ATLAS 2030 robotic exoskeletons for adult and pediatric neurorehabilitation respectively. The SR-TIGET gene therapy platform supports parallel development of therapies for lysosomal storage diseases (MPS IVA, GLB1-related disorders, and alpha-mannosidosis), and in March 2026 established the first Danaher Beacon in continental Europe via a multi-year partnership with Cytiva, Aldevron, and IDT to advance lentiviral vector production and gene editing. Digital infrastructure includes the SR Telemedicina platform for remote consultations, an integrated Single Reservation Center (CUP), online booking (prenotazioni.sanraffaele.it), and the Referti Online portal for report retrieval.

San Raffaele's business model operates through five principal revenue streams: regulated SSN tariff reimbursement across the accredited facility network; private-pay outpatient services and promotional screening packages (e.g., the SR Donna women's health screening package at €120); continuing medical education (ECM) courses delivered through its national ECM Provider status; PNRR and Fondazione Telethon research grants supporting SR-TIGET gene therapy programs; and ancillary services including home care (ADI – Assistenza Domiciliare Integrata). Customer access flows through GP/ASL referrals for SSN services, direct-to-consumer booking for private-pay offerings, and centralized Customer Care for international patients, with go-to-market spanning institutional SSN contracts, scientific conference participation, and event-driven reputation building.

San Raffaele firmographics

Firmographics
Name
San Raffaele
Legal name
San Raffaele S.p.A.
Website
https://sanraffaele.it
Company type
Private
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
San Raffaele S.p.A. operates an integrated Italian healthcare network (SR Network) of 16+ hospitals, rehabilitation centers, nursing homes, and outpatient clinics across Lazio, Abruzzo, Puglia, Basilicata, and Sardinia, with 4,000+ beds and 4,000+ health professionals serving general, rehabilitation, and elderly patients through SSN-accredited and private-pay services, including the IRCCS research hospital and the SR-TIGET gene therapy institute.
Ownership category
akta.pro rank

San Raffaele industry classification

Industry
Product category
Integrated Healthcare and Rehabilitation Services
NAICS
Home Health Care Services (62161), Nursing Care Facilities (Skilled Nursing Facilities) (62311), Diagnostic Imaging Centers (621512), Services for the Elderly and Persons with Disabilities (624120), Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Home Health Care Services (8082), Services-Skilled Nursing Care Facilities (8051), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Nursing & Personal Care Facilities (8050)
akta.pro primary industry
Home Health Therapy Services (PT/OT/SLP) Providers (HLAFAEAM)
akta.pro secondary industries
Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH), Private Duty 24/7 Nursing (RN/LPN) In-Home Care (HSABAHAJ)

Keywords

  • Rehabilitation services
  • Residential elderly care
  • Diagnostic imaging
  • Neurorehabilitation programs
  • Home healthcare services

Where San Raffaele is headquartered

Location

Headquarters

HQ city
Roma
HQ country
Italy
HQ region
Europe

Offices18 records

Markets served

San Raffaele business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Healthcare Service Delivery: Direct revenue from patient care services delivered across the SR Network of hospitals, rehabilitation centers, nursing homes (RSA), outpatient clinics, and home care (ADI). Services are provided both through the National Health Service (SSN/accreditation) and as private-pay. Revenue is generated from diagnostic procedures, specialist visits, inpatient stays, rehabilitation programs, and home care.
  2. National Health Service (SSN) Accreditations: Facilities operate under regional health system accreditation agreements, with funding flows from ASL (Aziende Sanitarie Locali) based on authorized capacity and service volume. Multiple subsidiaries hold separate SSN accreditations (Casa di Cura Nepi, Centro Geriatrico Matera, IRCCS San Raffaele Roma, Medica Group, Montecompatri, Nuova Nomentana Hospital, Portuense, Residenza dei Renai, Rocca di Papa, Rosa del Marganai, RSA San Raffaele Sabaudia, San Raffaele S.p.A., Villa dei Fiori, Villa Monica, Viterbo, SGAS).
  3. Continuing Medical Education (ECM): The San Raffaele Training Center is a National ECM Provider recognized by the Commissione Nazionale per la Formazione Continua, generating revenue from accredited training courses for healthcare professionals.
  4. Research Grants and PNRR Funding: IRCCS San Raffaele participates in projects funded by Italy's National Recovery and Resilience Plan (PNRR), with grants supporting gene therapy research, robotics rehabilitation, and translational medicine. Fondazione Telethon co-funds SR-TIGET gene therapy programs.
  5. Private-Pay Diagnostic and Screening Packages: Direct consumer revenue from promotional screening packages (e.g., SR Donna breast screening at €120) and private specialist consultations not covered by SSN.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSR Donna – Women's Health Screening Package
SubscriptionMulti-year contractSSN (National Health Service) Accredited Services
Usage-basedPay-as-you-goPrivate-Pay Specialist Consultations and Diagnostics

Go-to-market motion3 records

Distribution channels7 records

Marketing channels8 records

San Raffaele product offering

Product offering

Core offering

San Raffaele S.p.A. operates the SR Network, an integrated Italian healthcare system providing diagnostic imaging, specialist outpatient care, inpatient and residential rehabilitation (RSA), home care (ADI), and telemedicine through more than 16 facilities with 4,000+ beds and 4,000+ health professionals. Services are delivered both under Italian National Health Service (SSN) accreditation and as private-pay offerings, with a research arm (IRCCS San Raffaele and SR-TIGET) advancing gene therapy and neurorehabilitation science.

Product overview

San Raffaele is a comprehensive healthcare network (SR Network) providing integrated healthcare, scientific research, and assistance services through over 40 facilities with more than 4,000 beds and 4,000 health professionals. The network offers diagnostic imaging services (including 3D mammography with tomosynthesis, digital PET-TC with AI), rehabilitation services (neuromotor, equestrian rehabilitation, developmental age), telemedicine (SR Telemedicina), home care (ADI), outpatient specialist clinics, and operates research institutes including IRCCS San Raffaele for neuroscience and the San Raffaele-Telethon Institute for Gene Therapy. Patients can access services through online booking (CUP) and digital report retrieval.

Differentiator

Problem solved

Functional benefit

Products and services

  • SR Network (San Raffaele Healthcare Network) Integrated healthcare network providing diagnostics, specialist outpatient care, inpatient rehabilitation, residential elderly care (RSA), home care (ADI), and research services across multiple Italian regions.
  • Outpatient Specialist Clinics SSN-affiliated outpatient clinics offering specialist services including cardiology, dermatology, diagnostic imaging, endocrinology, gynecology, neurology, orthopedics, otolaryngology, physiatrics, speech therapy, ultrasound, and urology.
  • Specialized Rehabilitation Services (Neurorehabilitation and Equestrian Rehabilitation) Specialized rehabilitation including physical, mental, and sensory rehabilitation, equestrian rehabilitation, onotherapy, robotic exoskeleton therapy (EKSO, ATLAS 2030), music therapy, and neuroprosthetics. Includes 95 residential beds and 35 semiresidential beds at San Raffaele Viterbo.
  • ADI – Assistenza Domiciliare Integrata (Integrated Home Care) Integrated home care service delivering healthcare assistance to patients in their homes across the SR Network catchment area.
  • SR Telemedicina Telemedicine service enabling remote medical consultations, online report access, and home care coordination.
  • San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) Research institute developing gene therapy platforms for lysosomal storage diseases (MPS IVA, GLB1-related disorders, alpha-mannosidosis) and next-generation genomic medicine including lentiviral vector production and gene editing in hematopoietic stem cells.
  • IRCCS San Raffaele Neuroscience and Neurorehabilitation Unit Research and clinical unit focused on neuroscience and neurorehabilitation, including the CDCD (Centro Disturbi Cognitivi e Demenze), formally recognized as a Center of Excellence by Lazio Region.
  • San Raffaele Formazione (Continuing Medical Education / ECM Provider) National ECM Provider delivering accredited continuing medical education and specialized training programs for healthcare professionals.
  • SR Donna Women's Health Screening Package Private-pay women's health screening package combining gynecological consultation, Pap test, mammography, and breast ultrasound for early detection of breast and gynecological conditions.
  • Residential Care (RSA) Services Residential, semi-residential, hospice, and integrated home care services for elderly and non-self-sufficient adults, including dementia care (CDCD), across multiple SSN-accredited facilities.

Quantifiable outcome

  • Up to 30% dose reduction in mammography with maintained image quality (PRIME technology)
  • +4 more outcomes

Companies that use San Raffaele

Customer profile

Named customers5 records

Segments7 records

Ideal customer profiles8 records

San Raffaele technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature7 records

San Raffaele partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, supporting, core and minor.

  • Cytiva (Danaher company)flagshipStrategic or Co-development Partner · 23 March 2026Cytiva and SR-TIGET launched a multi-year collaboration to advance next-generation genomic medicine platforms, establishing the first Danaher Beacon on the European continent. The initiative focuses on optimizing lentiviral vector production and homology-directed repair-based gene editing in hematopoietic stem cells. SR-TIGET provides scientific leadership while Cytiva provides manufacturing expertise. Partners Aldevron and IDT also participate. The goal is to help developers overcome bottlenecks in cell and gene therapy translation, scalability, and reproducibility to make breakthrough advanced therapies more sustainable and accessible to patients.
  • AldevronsupportingTechnology or Integration · 23 March 2026Aldevron participates as a technology partner alongside Cytiva in the SR-TIGET genomic medicine collaboration, contributing to the Danaher Beacon initiative for cell and gene therapy manufacturing optimization.
  • IDTsupportingTechnology or Integration · 23 March 2026IDT participates alongside Cytiva and Aldevron in the SR-TIGET collaboration as a technology partner contributing to the Danaher Beacon genomic medicine platform for gene editing optimization.
  • Tosinvest SanitàcoreStrategic or Co-development Partner · 26 November 2004Tosinvest Sanità is the parent healthcare group of San Raffaele, organizing quality initiatives such as the World Quality Day in Healthcare with Fondazione San Raffaele, attended by Italian Ministry of Health officials. The group oversees the SR Network of healthcare facilities.
  • WHO (World Health Organization)minorStrategic or Co-development Partner · 17 November 2004San Raffaele served as venue and institutional partner for World COPD Day conference organized by the Italian Association of COPD Patients, under the auspices of the WHO and NIH, recognizing San Raffaele's translational research role in rehabilitation and prevention.
  • NIH – National Institutes of Health, BethesdaminorStrategic or Co-development Partner · 17 November 2004NIH Bethesda co-sponsored the World COPD Day conference held at San Raffaele, acknowledging San Raffaele's scientific contributions to respiratory rehabilitation and prevention research.
  • Ospedale Bambino GesùsupportingStrategic or Co-development PartnerIRCCS San Raffaele and Ospedale Bambino Gesù jointly organize the International Epilepsy Course (XIII edition in Tagliacozzo), combining clinical and research expertise in pediatric and adult epilepsy.
  • AREDA – Amateur Sports AssociationsupportingOthersAREDA provides technical support for equestrian rehabilitation activities at San Raffaele Viterbo's Equestrian Rehabilitation Center, including free-roaming Haflinger horses for therapy, mini ponies for children, and donkey onotherapy sessions.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

San Raffaele competitors and assessment

Company assessment

Broad incumbents

  • Gruppo San Donato: Italy's largest private hospital group, which notably owns the IRCCS Ospedale San Raffaele in Milan (distinct from the Rome-based San Raffaele S.p.A. analyzed here). Comparable as an Italian multi-facility hospital network with research capabilities and SSN-accredited operations.
  • Korían Group: Major European operator of nursing homes, rehabilitation clinics, and home care services with operations in France, Italy, Germany, and beyond. Comparable to San Raffaele's residential, rehabilitation, and home care (ADI) service lines.
  • emeis (formerly Orpea): Large European operator of nursing homes, post-acute and rehabilitation clinics. Comparable for the RSA/nursing home and rehabilitation components of San Raffaele's network, though at significantly larger scale.

Direct peers

  • Humanitas: Italian private hospital group with IRCCS-recognized research (Humanitas Research Hospital) and integrated care across multiple specialties. Directly comparable to San Raffaele as an Italian multi-site hospital/research network with SSN accreditation and academic partnerships.
  • Kos Group: Italian healthcare group operating hospitals, rehabilitation centers, nursing homes (RSA), and home care services. Closely matches San Raffaele's mix of rehabilitation, residential care, and acute services in Italy.
  • Villa Maria Group: Italian private hospital and rehabilitation network with multiple facilities across regions. Comparable for multi-site Italian hospital/rehabilitation operations and SSN accreditation model.
  • Segesta Group (Lifenet): Italian private healthcare operator focused on rehabilitation, RSA residential care, and psychiatric services. Directly comparable to San Raffaele's rehabilitation and elderly care footprint in central Italy.
  • Affidea: European operator of advanced diagnostic imaging centers (MRI, CT, PET-CT) including in Italy. Comparable to San Raffaele's diagnostic imaging investments (digital PET-CT, 3D mammography) at the facility/outpatient level.
  • Policlinico Universitario A. Gemelli IRCCS: Major Italian IRCCS university hospital in Rome with strong research portfolio. Comparable to IRCCS San Raffaele Roma in terms of designation, research prestige, and acute specialty services within the same metropolitan market.

Others

  • Fondazione Telethon: Italian non-profit funding gene therapy research, long-standing co-funder of SR-TIGET. Adjacent player — represents the demand-side ecosystem for San Raffaele's gene therapy platform rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

San Raffaele social profiles

Digital presence

San Raffaele financial estimates

Financial estimate

Revenue estimate

Valuation estimate

San Raffaele leadership team

Management profile

Number of profiles

Profiles13 records

San Raffaele subsidiaries and ownership

Company hierarchy

Subsidiaries15 records

San Raffaele funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

San Raffaele M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about San Raffaele

What does San Raffaele do?

San Raffaele S.p.A. operates the SR Network, an integrated Italian healthcare system providing diagnostic imaging, specialist outpatient care, inpatient and residential rehabilitation (RSA), home care (ADI), and telemedicine through more than 16 facilities with 4,000+ beds and 4,000+ health professionals. Services are delivered both under Italian National Health Service (SSN) accreditation and as private-pay offerings, with a research arm (IRCCS San Raffaele and SR-TIGET) advancing gene therapy and neurorehabilitation science.

Is San Raffaele a public or private company?

San Raffaele is a private company. It is classified as corporate owned and is currently operating.

When was San Raffaele founded?

San Raffaele was founded in -1. It employs 1,001 to 5,000 people.

Where is San Raffaele based?

San Raffaele is headquartered in Roma, Italy, in the Europe region.

How does San Raffaele make money?

Five revenue lines are on record. Healthcare Service Delivery is the primary driver. The others are national Health Service (SSN) Accreditations, continuing Medical Education (ECM), research Grants and PNRR Funding and private-Pay Diagnostic and Screening Packages.

Who are San Raffaele's main competitors?

Broad incumbents on record are Gruppo San Donato, Korían Group and emeis (formerly Orpea). Direct peers are Humanitas, Kos Group, Villa Maria Group, Segesta Group (Lifenet), Affidea and Policlinico Universitario A. Gemelli IRCCS. Fondazione Telethon is listed as an others.

Does San Raffaele have an API?

No public API is recorded for San Raffaele.

What industry is San Raffaele in?

San Raffaele's product category is Integrated Healthcare and Rehabilitation Services. Its primary akta.pro industry code is HLAFAEAM, Home Health Therapy Services (PT/OT/SLP) Providers, with a secondary code of HLALABAD, Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BeBeezSan Raffaele spa di Angelucci acquisisce il complesso aziendale di Nomentana Hospital in composizione negoziata - BeBeezSan Raffaele spa acquired Nomentana Hospital's entire corporate complex via negotiated composition, with the price undisclosed. The hospital, the largest accredited private care facility in Lazio, has over 550 beds and was facing liquidity issues, prompting the sale.FondazionetelethonCytiva and San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) launch collaboration to advance next-generation genomic medicine platformsCytiva, a Danaher company, and the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) have launched a collaboration to advance next-generation genomic medicine platforms, establishing the first Danaher Beacon on the European continent. The initiative will focus on optimizing lentiviral vector production and homology-directed repair-based gene editing in hematopoietic stem cells, combining SR-TIGET's scientific leadership with Cytiva's manufacturing expertise alongside partners Aldevron and IDT. The multi-year collaboration aims to help developers overcome bottlenecks in cell and gene therapy translation, scalability, and reproducibility to make breakthrough advanced therapies more sustainable and accessible to patients.FondazionetelethonGene therapy platform for lysosomal storage diseasesThe San Raffaele–Telethon Institute for Gene Therapy (SR-TIGET) has launched a platform project enabling parallel development of gene therapies for multiple lysosomal storage diseases, including MPS IVA, GLB1-related disorders, and alpha-mannosidosis, rather than traditional single-disease development. The platform approach standardizes preclinical, productive, and clinical steps across diseases that share common biological characteristics, with vector preparation and toxicology studies conducted using shared control groups. Funding for the project comes from Fondazione Telethon and Italy's National Recovery and Resilience Plan (PNRR), with the project currently in preclinical development and a single combined clinical trial planned for all three disease groups.Eyes On EyecareStudy identifies key risk factors for punctate inner choroidopathy patientsA retrospective cohort study conducted at San Raffaele Hospital in Milan, Italy, analyzed 135 patients (175 eyes) with punctate inner choroidopathy (PIC) over an average follow-up of 7.1 years to identify risk factors for visual impairment and structural complications. The study found that while mean visual acuity remained stable overall, 79% of eyes developed complications by follow-up, with macular neovascularization (MNV) affecting 57% at presentation and 17% developing it during follow-up at an incidence rate of 11.1 per 100 eye-years. Researchers identified that lacquer cracks doubled MNV risk (HR: 2.00) while immunomodulatory therapy (HR: 0.61) and posterior staphyloma (HR: 0.52) were protective factors, concluding that early identification and prompt anti-inflammatory treatment may help preserve long-term visual function.The Hollywood ReporterSilvio Berlusconi, Flamboyant and Controversial Italian Media Tycoon and Former Prime Minister, Dies at 86Silvio Berlusconi, Italian media tycoon and former prime minister, died at 86 at San Raffaele Hospital in Milan. He had been admitted for chronic leukemia treatment. Berlusconi was known for his media empire, political power, and controversial lifestyle.PR NewswireAcellular-Convalescent Plasma (A-CP) and New Technologies Introduced by Regen Lab®Swiss medical device company Regen Lab SA announced the launch of its Acellular-Convalescent Plasma (A-CP) tube, a 20 ml device for standardized production of 10 ml convalescent plasma for COVID-19 treatment, coinciding with US-FDA approval of convalescent plasma therapy. Evaluations conducted by Dr. Luca Santoleri at San Raffaele Hospital in Milan demonstrated near 100% recovery of IgG antibodies without cellular contamination, with processing time of 20 minutes compared to over 24 hours for conventional plasmapheresis. The company also received a new CE mark valid until May 2024, renewed its MDSAP audit, published a new book on standardized PRP, and secured seven new patents in Israel, South Korea, Europe, India, and Eurasia.PR Newswire€12.6 Million Awarded to 3 Projects in Global Effort to End Progressive Multiple SclerosisThe International Progressive MS Alliance awarded three Collaborative Network Award grants worth €4.2 million each, totaling €12.6 million, to accelerate research into progressive multiple sclerosis through international research networks. The three funded projects involve researchers from institutions including McGill University, San Raffaele Hospital Milan, and Brigham and Women's Hospital, collaborating across 10 countries to develop MRI biomarkers, identify therapeutic drug compounds, and create drug discovery pipelines targeting progressive MS. One project aims to have candidate drugs ready for patient evaluation within four years, with another potentially entering clinical trials by end of 2020.PR NewswirePoint Guard Biosciences Announces Winner of Innovation in Ophthalmology AwardPoint Guard Biosciences announced Dr. Giulio Ferrari from San Raffaele Hospital, Milan, as the winner of its inaugural Innovation in Ophthalmology Award for his research on using neurokinin 1 receptor (NK1-R) antagonists to treat corneal neovascularization. The award provides a $10,000 cash prize and strategic assistance with developing a business plan, selected from 31 global applications. The program is part of PGBio's mission to support ophthalmology entrepreneurs with funding and strategic planning resources to advance treatments for unmet medical needs.